The proposed 100,000-square-foot center would offer outpatient chemotherapy, radiation, pain management and imaging. The suburban community hospitals argue the facility would draw their patients away because of Memorial’s reputation. The local patients are particularly valuable because of their high income: The yearly median family income in Scarsdale, located a few minutes from Harrison, was approximately $230,000 the past few years, according to the report.
However, Victor Ribaudo, executive director of Memorial’s regional care network, said Memorial was only looking to meet a need in the community, according to the report. The state health department’s staff has recommended approval, claiming there are sufficient cancer cases in the area to support a new center and Memorial already treats many suburban patients who travel to the city for care.
White Plains (N.Y.) Hospital, Hudson Valley Hospital Center in Cortlandt Manor, Lawrence Hospital Center in Bronxville, Northern Westchester Hospital in Mount Kisco and Westchester Medical Center in Valhalla would be most affected by the center, according to the report.
The New York health commissioner will decide whether Memorial Sloan-Kettering can build the facility based on a planning council’s recommendation, which is meeting today.
Related Articles on Hospital Specialty Center Construction:
Kentucky Children’s Hospital Opens Congenital Heart Clinic
Boston’s Beth Israel Deaconess Plans $20M Cancer Center in Needham
Georgia’s Gwinnett Medical Center Opens Breast Center
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
